Table 1.
Age, gender composition, and size of each cohort analyzed in the present study
| N Male | N Female | N Not Reported | Total | Mean (SD) Age | |
|---|---|---|---|---|---|
| Overall Cohorts | |||||
| ADHD + | 9359 (6.50%) | 8779 (6.10%) | 1579 (1.09%) | 19,717 (13.71%) | 40.35 (15.91) |
| ADHD − | 43,608 (30.32%) | 71,437 (49.67%) | 9044 (6.28%) | 124,089 (86.28%) | 52.58 (16.41) |
| Total | 52,967 (36.83%) | 80,216 (55.78%) | 10,623 (7.38%) | 143,806 (100%) | 50.90 (16.87) |
| Baseline Cohorts | |||||
| ADHD-SRLD | |||||
| ≥1 NCPT | 9109 (47.27%) | 8603 (44.65%) | 1555 (8.07%) | 19,267 (100%) | 40.44 (15.92) |
| ≥1 BAMS-7 | 1452 (49.13%) | 1379 (46.66%) | 124 (4.19%) | 2955 (100%) | 39.38 (16.19) |
| Healthy Controls | |||||
| ≥1 NCPT | 16,211 (36.14%) | 26,170 (58.34%) | 2471 (5.50%) | 44,852 (100%) | 50.79 (16.57) |
| ≥1 BAMS-7 | 11,606 (42.47%) | 14,654 (53.62%) | 1065 (3.89%) | 27,325 (100%) | 47.17 (16.95) |
| Efficacy Cohorts | |||||
| ADHD-SRLD | |||||
| ≥2 NCPT | 3182 (44.39%) | 3443 (48.03%) | 542 (7.56%) | 7167 (100%) | 44.28 (16.15) |
| ≥2 BAMS-7 | 326 (42.72%) | 411 (53.86%) | 26 (3.40%) | 763 (100%) | 44.33 (16.32) |